PI: Bradley Stein, MD, PhD
Amount: $358,422
Timeline: Mar. 2021 - Oct. 2022
Area: Policy Initiatives
Cohort: COVID-19 Response

    on Social:

Buprenorphine Treatment for Opioid Use Disorder During the COVID-19 Pandemic and the Role of State Policy Changes

This project will investigate changes in buprenorphine prescribing during the pandemic and how these changes may have affected access to care and treatment outcomes among underserved populations, including Medicaid beneficiaries and rural populations. The investigator will explore how the observed changes in prescribing relate to different state policies. The analysis will inform decisions about whether to continue or adapt COVID-era policies intended to preserve access to treatment.